Track topics on Twitter Track topics that are important to you
The U.K.’s LifeArc (previously MRC Technology), Defense Science and Technology Laboratory (Dstl) and Canada’s Centre for Drug Research and Development (CDRD) established a partnership to identify novel antibacterial targets as the foundation for multi-drug resistance (MDR) antibiotic drug discovery and development.programs. The organizations say that while antibacterial drug discovery has to date focused primarily on single species resistance, the LifeArc, CDRD and Dstl partnership will take 'a more holistic approach, and focus on commonality across species to identify drug resistance genes and proteins. The most promising validated targets will be then be published and potentially progressed into drug discovery. Professor Timothy Atkins, senior fellow at Dstl, said the ability to protect both the civilian population and armed forces against infectious diseases will involve developing new antibacterial agents against a broad spectrum of pathogens. "To achieve this challenging goal we need to be working with scientists at the ...NEXT ARTICLE
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...